While associations between the two conditions have been documented in the literature, a new study led by Cleveland Clinic investigators is the first to suggest a bidirectional link and to reveal the impact of IBD treatment on celiac disease.
Gastroenterologist Alberto Rubio Tapia, MD, an internationally recognized authority on celiac disease (CD), has joined Cleveland Clinic to create a comprehensive CD treatment and research program.
Yes, it’s real. Recent research reveals systemic immune activation and gut epithelial damage in response to gluten – in patients without celiac disease
A Cleveland Clinic gastroenterologist breaks new ground with the use of noninvasive exhaled breath testing as a screening tool in pediatric medicine.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
After demonstrating that breath analysis can detect pediatric nonalcoholic fatty liver disease, Cleveland Clinic Children’s is assessing the technique’s utility in diagnosing other pediatric gastrointestinal conditions.
A faculty of over 50 pediatric experts explores practice implications of the year’s most important advances in pediatric care June 11-13 at Cleveland Clinic Children’s Pediatric Innovation Summit.
Celiac disease is more than twice as common in people with cirrhosis of the liver than in the general population, a new study says — indicating that routine screening for Celiac disease may be warranted for these patients.
Low-grade inflammation in celiac disease doubles the risk of coronary artery disease in patients of any age.